吉西他滨，CAS 登记号 95058-81-4，由济南圣和化工有限公司现货供应，可提供纯度 按批次COA提供(不公开发布) 的规格，下游主要用于有机化学品。支持样品与小批量试用，批量价格请联系我们获取，验收以批次 COA 为准。
有机化学品
每批随货提供 COA；可按需提供 MSDS 及技术文件。邮件注明产品名称与 CAS 号，一个工作日内回复报价。
本页已列出 吉西他滨 的 CAS 号：95058-81-4，可与随货 COA 核对。
常见纯度为 按批次COA提供(不公开发布)，包装形式为 按订单/批次确认(不公开发布)，特殊规格可在询价时说明。
主要涉及有机化学品。
来信 info@591daili.com 或 WhatsApp 联系，提供产品名称、CAS 号与数量，确认价格与交期后即可安排发货，验收以批次 COA 为准。
Gemcitabine · CAS 95058-81-4 · C9H11F2N3O4. UNII HMS3655E04.
| CAS Registry Number | 95058-81-4 |
|---|---|
| PubChem CID | 3461 |
| Molecular formula | C9H11F2N3O4 |
| IUPAC name | 4-amino-1-[3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one |
| UNII (FDA) | HMS3655E04 |
| Molecular Weight | 263.20 |
|---|---|
| XLogP3 | -1.5 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 2 |
| Exact Mass | 263.07176216 |
| Monoisotopic Mass | 263.07176216 |
| Topological Polar Surface Area | 108 |
| Heavy Atom Count | 18 |
| Formal Charge | 0 |
701937-51-1; 4-amino-1-[3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2-dihydropyrimidin-2-one; 3'-Epi Gemcitabine (Gemcitabine Impurity); 4-amino-1-[3,3-difluoro-4-hydroxy-5-(hydroxymethyl)-2-oxolanyl]-2-pyrimidinone; 4-amino-1-[3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one; Gemctitabine; Neuro_000239; SCHEMBL94960; CHEMBL264883; CHEBI:93766; SDUQYLNIPVEERB-UHFFFAOYSA-N; HMS3655E04; HMS5079H16; 2;-Deoxy-2',2'-difluorocytidine; EBC-70048; NSC750927
CAS 95058-81-4; molecular formula C9H11F2N3O4; molecular weight — g/mol.
701937-51-1, 4-amino-1-[3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2-dihydropyrimidin-2-one, 3'-Epi Gemcitabine (Gemcitabine Impurity), 4-amino-1-[3,3-difluoro-4-hydroxy-5-(hydroxymethyl)-2-oxolanyl]-2-pyrimidinone, 4-amino-1-[3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one, Gemctitabine.
Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.